TITLE

Alzheimer's Test Offers Early Diagnosis

PUB. DATE
September 2010
SOURCE
Pharmaceutical Representative;Sep2010, Vol. 40 Issue 9, p9
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on a study conducted by researchers in Belgium which discovered a test that has proven successful at identifying patients that are developing Alzheimer's disease.
ACCESSION #
53550408

 

Related Articles

  • NEWS IN BRIEF.  // ASHA Leader;5/18/2010, Vol. 15 Issue 6, p3 

    The article presents information about several medical studies in the U.S. including the identification of a gene on chromosome that may increase a person's risk of developing late-onset Alzheimer's disease, children with cleft lip palate who receive care from a team are more likely to have...

  • Do NSAIDs Protect Patients Against Alzheimer's Disease? Walling, Anne D. // American Family Physician;2/15/2004, Vol. 69 Issue 4, p944 

    Comments on the role of physician in interpreting media reports of research studies for patients. Possible effect of irresponsible reporting on Alzheimer's disease patients.

  • Plasma level of chitinase 3-like 1 protein increases in patients with early Alzheimer's disease. Choi, Jihye; Lee, Ho-Won; Suk, Kyoungho // Journal of Neurology;Dec2011, Vol. 258 Issue 12, p2181 

    Previously, chitinase 3-like 1 (CHI3L1) protein level was increased in various inflammatory conditions and cancers. This study was aimed to evaluate the plasma CHI3L1 level as a potential prognostic biomarker for Alzheimer's disease (AD). Forty-nine patients with mild cognitive impairment (MCI),...

  • 2008 - High-dose vitamin B supplements did not slow cognitive decline in mild-to-moderate Alzheimer disease. Gill, Sudeep S. // ACP Journal Club;2/17/2009, Vol. 150 Issue 2, p5 

    The article presents a research conducted by P.S. Aisen and colleagues to find whether high-dose vitamin B supplements did not slow cognitive decline in mild-to-moderate Alzheimer disease (AD). 409 patients of 50 years of age who had probable AD and scored 14 to 26 on the Mini-Mental State...

  • Independent Nurse: Journals Watch.  // GP: General Practitioner;10/9/2009, p7 

    The article offers information on the result of several studies, related to the field of medicine. According to a study, patients struggle with financial skills, in the year before they develop Alzheimer's disease. It mentions that more than 20 percent of suicide cases in the U.S. are linked to...

  • Amyloid beta-peptide and Alzheimer's.  // Caribbean Health;Oct2000, Vol. 3 Issue 3, p32 

    The article presents a medical research related to neuropathological characteristics of amyloid beta-peptide and Alzheimer's disease in New York. It states that the neuropathological characteristics of Alzheimer's disease include brain plaques containing amyloid β peptide and neurofibrillary...

  • Financings Roundup.  // BioWorld Today;9/13/2007, Vol. 18 Issue 178, p3 

    The article reports that Australian firm Prana Biotechnology Ltd. has raised funds to support ongoing development of the company's lead compound PBT2, which is in a Phase IIa trial in Alzheimer's disease patients. The company raised A$7 million through a private placement of about 24.6 million...

  • PFIZER ANNOUNCES NEW PHASE 1 DATA FROM TWO NOVEL COMPOUNDS FOR ALZHEIMER'S DISEASE AT ICAD ANNUAL MEETING.  // Psychiatry (1550-5952);Aug2009, Vol. 6 Issue 8, p41 

    The article presents the results of two Phase 1 safety studies, one of a humanized antiamyloid monoclonal antibody (mAb) PF-04360365, and another of dimebon, in patients with Alzheimer's disease. It notes that the data were presented at the Alzheimer's Association 2009 International Conference...

  • Doubts on antipsychotic use.  // Pulse;4/9/2008, Vol. 68 Issue 12, p13 

    The article reports that British researchers found antipsychotic treatment with no cognitive or neuropsychiatric benefits for patients with Alzheimer's disease. It has been suggested that this treatment should only be used as a last resort. Their trial of 165 patients taking neuroleptic drugs...

  • Minerva. Whitehouse, Michael R. // BMJ: British Medical Journal (International Edition);9/3/2005, Vol. 331 Issue 7515, p524 

    Offers news briefs pertaining to medical research. The cause of "cyclist palsy" in long-distance cyclists; Data indicating the optimal time to undergo carotid endarterectomy after a stroke; Finding of the Framingham heart study that high blood pressure means a shorter life expectancy in general;...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics